BOSTON SCIENTIFIC CORP filed this 4 on November 25, 2024
BOSTON SCIENTIFIC CORP - 4 - 20241125 - EXPLANATIONS_AND_REMARKS
Explanation of Responses:
(1) The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.
(2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $88.76 to $89.74 inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
(3) Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
(4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
(5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.